Yellow Fever Vaccine and Multiple Sclerosis
Introduction to Transmission Risks
- The Advisory Committee on Immunization Practices (ACIP) guidelines state that there is no evidence of person-to-person transmission of the yellow fever vaccine virus through intimate contact, allowing patients with Multiple Sclerosis (MS) to safely sleep with someone who has received the vaccine 1
- The yellow fever vaccine virus has not been documented to spread from person to person through casual contact, sexual contact, or sleeping arrangements, according to the ACIP guidelines 1
- Blood donation centers should defer donors who received yellow fever vaccine within the preceding 2 weeks, as per the ACIP guidelines 1
Vaccine Contraindications and Precautions
- The American Academy of Neurology and other neurology guidelines suggest that yellow fever vaccine is generally contraindicated in MS patients due to potential risks of exacerbation, with an increase in MS relapses noted in some yellow fever vaccine recipients with pre-existing MS 2
- Yellow fever vaccine is generally not recommended for immunocompromised persons, including some MS patients on immunosuppressive therapies, as stated by the Centers for Disease Control and Prevention (CDC) and other public health guidelines 2
Risk Assessment for MS Patients
- The direct transmission risk of yellow fever vaccine virus to an MS patient sleeping with someone who received the vaccine is none documented through intimate contact, based on available evidence 1
- The indirect risk to household contacts or intimate partners of yellow fever vaccine recipients is also none documented, according to the CDC and other public health guidelines 1
- Unlike oral polio vaccine (OPV), which has documented household transmission and risk of vaccine-associated paralytic poliomyelitis in contacts, yellow fever vaccine has no documented similar risk, as stated by the World Health Organization (WHO) and other global health authorities 2
Special Considerations for MS Patients on Immunosuppressive Therapies
- The concern is primarily about the MS patient receiving the vaccine themselves, not about contact with vaccinated individuals, as emphasized by the National Multiple Sclerosis Society and other patient advocacy groups
- The vaccinated partner should not donate blood for 2 weeks after vaccination, to prevent potential transmission of the vaccine virus through blood products, as recommended by the ACIP guidelines 1
Conclusion and Recommendations
- MS patients do not need to avoid intimate contact with yellow fever vaccine recipients, based on available evidence and guidelines from the CDC and other public health authorities 1
- MS patients should continue routine monitoring of their condition as per their regular care plan, with no special precautions needed regarding contact with yellow fever vaccine recipients, as recommended by the American Academy of Neurology and other neurology guidelines 1